Literature DB >> 32820880

Treating anxious syndromes with pregabalin in patients with psychosis.

Nicolas Garel1, David Bloom1, Ridha Joober1.   

Abstract

Entities:  

Year:  2020        PMID： 32820880      PMCID： PMC7850152          DOI： 10.1503/jpn.200033

Source DB:  PubMed          Journal:  J Psychiatry Neurosci        ISSN： 1180-4882            Impact factor:   6.186


× No keyword cloud information.
  9 in total

1.  Augmentation with pregabalin in schizophrenia.

Authors:  Susanne Englisch; Andrea Esser; Frank Enning; Sarah Hohmann; Heike Schanz; Mathias Zink
Journal:  J Clin Psychopharmacol       Date:  2010-08       Impact factor: 3.153

Review 2.  Pregabalin pharmacology and its relevance to clinical practice.

Authors:  Elinor Ben-Menachem
Journal:  Epilepsia       Date:  2004       Impact factor: 5.864

3.  Pregabalin in the treatment of schizophrenic anxiety.

Authors:  C Schönfeldt-Lecuona; R C Wolf; N D Osterfeld; N Vasic; B J Connemann; M Schmid; R W Freudenmann
Journal:  Pharmacopsychiatry       Date:  2009-05-18       Impact factor: 5.788

4.  Pregabalin for anxiety in patients with schizophrenia - A randomized, double-blind placebo-controlled study.

Authors:  Ole Schjerning; Per Damkier; Signe Engelhardt Lykkegaard; Klaus Damgaard Jakobsen; Jimmi Nielsen
Journal:  Schizophr Res       Date:  2017-09-15       Impact factor: 4.939

Review 5.  Current and potential pharmacological and psychosocial interventions for anxiety symptoms and disorders in patients with schizophrenia: structured review.

Authors:  Fleur M Howells; David G Kingdon; David S Baldwin
Journal:  Hum Psychopharmacol       Date:  2017-08-15       Impact factor: 1.672

6.  Quality of life in schizophrenia: contributions of anxiety and depression.

Authors:  J D Huppert; K A Weiss; R Lim; S Pratt; T E Smith
Journal:  Schizophr Res       Date:  2001-09-01       Impact factor: 4.939

Review 7.  Canadian clinical practice guidelines for the management of anxiety, posttraumatic stress and obsessive-compulsive disorders.

Authors:  Martin A Katzman; Pierre Bleau; Pierre Blier; Pratap Chokka; Kevin Kjernisted; Michael Van Ameringen; Martin M Antony; Stéphane Bouchard; Alain Brunet; Martine Flament; Sophie Grigoriadis; Sandra Mendlowitz; Kieron O'Connor; Kiran Rabheru; Peggy M A Richter; Melisa Robichaud; John R Walker
Journal:  BMC Psychiatry       Date:  2014-07-02       Impact factor: 3.630

8.  Dose-response relationship of pregabalin in patients with generalized anxiety disorder. A pooled analysis of four placebo-controlled trials.

Authors:  P Bech
Journal:  Pharmacopsychiatry       Date:  2007-07       Impact factor: 5.788

9.  Intentional Drug Overdose Involving Pregabalin and Gabapentin: Findings from the National Self-Harm Registry Ireland, 2007-2015.

Authors:  Caroline Daly; Eve Griffin; Darren M Ashcroft; Roger T Webb; Ivan J Perry; Ella Arensman
Journal:  Clin Drug Investig       Date:  2018-04       Impact factor: 2.859
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.